Are you above the legal age to view this content in your province/state?

Home / investmentvaluefinders

investmentvaluefinders

FSD PHARMA signs agreement with Covar Pharmaceuticals to support the development of LUCID

FSD Pharma Inc., a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today it has entered into an agreement with Covar Pharmaceuticals Inc. (“Covar”), a contract development and manufacturing services organization (“CDMO”), to commence work on providing research quantities of FSD’s drug candidate, …

Read More »

Cannabis store expansion in Canada strongly linked to sales growth, but weakly related to prevalence growth

Cannabis store expansion in Canada strongly linked to sales growth, but weakly related to prevalence growth

The growth in cannabis retail stores between 2018 and 2020 was driven by more than just the move to legalize recreational weed three years ago, suggests a new Canadian study. “From 2018 to 2020, Canada’s rapid cannabis retail expansion was strongly related to legal sales growth, but only weakly related …

Read More »

Starting Social Security at 62 Could Net You an Extra $20,000 in This Situation

Starting Social Security at 62 Could Net You an Extra $20,000 in This Situation

There are few hard-and-fast rules when it comes to Social Security. You may have heard some people say that it’s not a good idea to sign up for benefits right away at 62 because you’ll shrink your checks. While this is true, that doesn’t mean it’s always the wrong move. …

Read More »

FSD Pharma Announces Closing of Lucid Psycheceuticals Acquisition

FSD Pharma Announces Closing of Lucid Psycheceuticals Acquisition

Lucid Adds Potential for Neurodegenerative Disease Treatments and Mental Health in a Novel Way TORONTO–(BUSINESS WIRE)–FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, is pleased to announce the completion …

Read More »

Down 50% From Its High, Is Zoom Stock a Smart Buy?

Down 50% From Its High, Is Zoom Stock a Smart Buy?

Zoom Video Communications (NASDAQ:ZM) is a great example of the Gartner Hype Cycle in action. If you’re unfamiliar with the Hype Cycle, it depicts the perceived value of a new technology or trend over time. Generally speaking, expectations tend to be too high at first, then too low, before finding common ground somewhere in the …

Read More »

FSD PHARMA ANNOUNCES ENGAGEMENT WITH CAPITAL MARKETS COMMUNICATIONS PROVIDERS AND MARKET MAKER

FSD PHARMA ANNOUNCES ENGAGEMENT WITH CAPITAL MARKETS COMMUNICATIONS PROVIDERS AND MARKET MAKER

TORONTO–(BUSINESS WIRE)– FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today it has retained the services of Hybrid Financial Ltd. (“Hybrid”), North Equities Corp. (the “North Equities“), Looking …

Read More »

Could This Little-Known Pot Stock Double Your Money?

Could This Little-Known Pot Stock Double Your Money?

Key Points High Tide will have more than 100 cannabis stores across Canada by the end of this year.The company just expanded into the U.S. by acquiring online retailer Fab Nutrition.Over the next 12 months, its sales are on track to top more than 200 million Canadian dollars. There are …

Read More »

FSD PHARMA ANNOUNCES CLOSING OF LUCID PSYCHECEUTICALS ACQUISITION

FSD PHARMA ANNOUNCES CLOSING OF LUCID PSYCHECEUTICALS ACQUISITION

Lucid Adds Potential for Neurodegenerative Disease Treatments and Mental Health in a Novel Way TORONTO–(BUSINESS WIRE)– FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, is pleased to announce the …

Read More »

Lululemon shares surge on earnings beat, hiked outlook as shoppers spend on workout apparel

Lululemon shares surge on earnings beat, hiked outlook as shoppers spend on workout apparel

Based on its current forecast, Lululemon is now on track to surpass its 2023 revenue target by the end of this year, two years ahead of schedule. Lululemon shares surged more than 13% in extended trading Wednesday after the athletic apparel maker reported fiscal second-quarter profit and revenue that topped analysts’ …

Read More »

Disclaimer

Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.


Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.


DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.


Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.


Investment Value Finders is intended for those 21+ years of age only!